WPRIM Management System> DCMS> Gut and Liver> 2009> 3> 1

Volume: 3 Issue: 1

1. Immune Activation and Gut Microbes in Irritable Bowel Syndrome. Page:14—19
2. Optimizing the Dose and Duration of Therapy for ChronicHepatitis C . Page:1—13
3. Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation. Page:60—63
4. Acute Pancreatitis Complicating Spontaneous Acute Exacerbation of Chronic Hepatitis B Virus Infection: Case Report and Review of the Literature. Page:64—66
5. Colorectal Neoplasm in Asymptomatic Average-risk Koreans: The KASID Prospective Multicenter Colonoscopy Survey. Page:35—40
6. Treatment of Gastric Candidiasis in Patients with Gastric Ulcer Disease: Are Antifungal Agents Necessary?. Page:31—34
7. Plasma 5-Hydroxytryptamine Concentration and Its Correlation with Psychopathology in Patients with Irritable Bowel Syndrome. Page:26—30
8. Recombinant Interferon-Beta-1alpha Plus Ribavirin for the Treatment of Chronic HCV Infection: A Prospective, Randomized, Comparative Pilot Study. Page:20—25
9. Primary Rectal Amyloidosis in a Patient with Human Immunodeficiency Virus. Page:57—59
10. Reactivation of Pulmonary Tuberculosis in a Patient with Polygonum multiflorum Thunb-Induced Hepatitis. Page:52—56
11. Pyogenic Granuloma of the Duodenum Treated Successfully by Endoscopic Mucosal Resection. Page:48—51
12. Cytapheresis in Patients with Severe Ulcerative Colitis after Failure of Intravenous Corticosteroid: A Long-Term Retrospective Cohort Study. Page:41—47

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.